ATH alterity therapeutics limited

Future drug compounds

  1. 4,154 Posts.
    lightbulb Created with Sketch. 423
    Incase you missed Pivaldes statement around the corporate presentation. Highly recommend reading pages 24-26. Than also pages 26-37.

    I'm abit blown away by it all, and the number of patencies Alterity hold and have applied for.

    Alterity, as they state, have a robust number of compounds in their library, which are being tested by scientist at Bio21 institute in Melbourne, which they are also gaining patency of these compounds.

    The compounds being tested appear to also be far reaching outside of just parkinsons, which is pretty bloody exciting to read, and excredibly happy to be a holder of this company.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.000(0.00%)
Mkt cap ! $119.7M
Open High Low Value Volume
1.3¢ 1.3¢ 1.3¢ $118.5K 9.116M

Buyers (Bids)

No. Vol. Price($)
37 19719503 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 3622343 8
View Market Depth
Last trade - 15.59pm 09/09/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.